Slc2a12 | solute carrier family 2 (facilitated glucose transporter), member 12
Physiological systems
17 / 24 physiological systems tested
1 Significantly impacted by the knock-out
Cardiovascular system
16 No significant impact
7 Not tested
Data collections
Gene metrics:2Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
increased heart left ventricle size | 1 supporting dataset | Slc2a12em2(IMPC)Bay | homozygote | Early adult | 2.64x10-5 | ||
thick ventricular wall | 1 supporting dataset | Slc2a12em2(IMPC)Bay | homozygote | Early adult | 5.62x10-5 |
| | | | | | | | | |
External links
No external links available for Slc2a12.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Slc2a12em1(IMPC)Bay | | mouse | |
Slc2a12em2(IMPC)Bay | Exon Deletion | | mouse |
Slc2a12tm360435(L1L2_Bact_P) | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector |